(ADAP) Adaptimmune Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Adaptimmune Therapeutics | (ADAP) share price targets
Complete technical analysis of Adaptimmune Therapeutics (ADAP) by charts plus indicators, forecast predictions and share price targets for Adaptimmune Therapeutics (ADAP)
Adaptimmune Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2025-10-15 View latest technical analysis
10 day averaged volume of Adaptimmune Therapeutics is 114959474
Date | Daily Closing Price | Open | High | Low | Volume |
15 Wed Oct 2025 | 0.18 | 0.17 | 0.20 | 0.16 | 0.646 times |
14 Tue Oct 2025 | 0.16 | 0.16 | 0.17 | 0.15 | 0.407 times |
13 Mon Oct 2025 | 0.18 | 0.19 | 0.21 | 0.18 | 0.343 times |
10 Fri Oct 2025 | 0.18 | 0.21 | 0.21 | 0.18 | 0.601 times |
09 Thu Oct 2025 | 0.22 | 0.27 | 0.28 | 0.20 | 2.155 times |
08 Wed Oct 2025 | 0.21 | 0.17 | 0.24 | 0.15 | 4.845 times |
07 Tue Oct 2025 | 0.14 | 0.14 | 0.15 | 0.14 | 0.288 times |
06 Mon Oct 2025 | 0.14 | 0.16 | 0.16 | 0.13 | 0.308 times |
03 Fri Oct 2025 | 0.14 | 0.13 | 0.16 | 0.12 | 0.545 times |
02 Thu Oct 2025 | 0.13 | 0.13 | 0.14 | 0.12 | 0.261 times |
My analysis of stock is bullish for shortterm, and stock might move up till 0.2 or till 0.2. Use a stoploss of 0.16 and if this stock hits its stoploss, then it can fall down till 0.13
Share price targets for Adaptimmune Therapeutics (ADAP)
Target Type | Value |
Downside Target | 0.04 |
Downside Target | 0.05 |
Downside Target | 0.06 |
Downside Target | 0.08 |
Downside Target | 0.12 |
Downside Target | 0.13 |
Downside Target | 0.15 |
Downside Target | 0.16 |
Upside Target | 0.19 |
Upside Target | 0.21 |
Upside Target | 0.23 |
Upside Target | 0.28 |
Upside Target | 0.31 |
Upside Target | 0.36 |
Intraday share price targets for Adaptimmune Therapeutics (ADAP)
Target Type | Value |
Downside Intraday Target | 0.15 |
Downside Intraday Target | 0.12 |
Upside Intraday Target | 0.21 |
Upside Intraday Target | 0.24 |
Upside Intraday Target | 0.18 |
Weekly technical analysis of Adaptimmune Therapeutics (ADAP)
Date | Weekly Closing Price | Open | High | Low | Volume |
15 Wed Oct 2025 | 0.18 | 0.19 | 0.21 | 0.15 | 0.17 times |
10 Fri Oct 2025 | 0.18 | 0.16 | 0.28 | 0.13 | 4.953 times |
03 Fri Oct 2025 | 0.14 | 0.16 | 0.16 | 0.12 | 0.433 times |
26 Fri Sep 2025 | 0.15 | 0.15 | 0.19 | 0.12 | 0.223 times |
19 Fri Sep 2025 | 0.14 | 0.06 | 0.23 | 0.06 | 12.354 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Adaptimmune Therapeutics (ADAP)
Date | Monthly Closing Price | Open | High | Low | Volume |
15 Wed Oct 2025 | 0.18 | 0.13 | 0.28 | 0.12 | 0.443 times |
30 Tue Sep 2025 | 0.13 | 0.06 | 0.23 | 0.04 | 1.59 times |
29 Fri Aug 2025 | 0.06 | 0.09 | 0.12 | 0.05 | 6.14 times |
31 Thu Jul 2025 | 0.08 | 0.24 | 0.36 | 0.08 | 21.89 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Adaptimmune Therapeutics (ADAP)
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Adaptimmune Therapeutics in short term and the buy signal is strong.
Adaptimmune Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Adaptimmune Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Adaptimmune Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.2 and Adaptimmune Therapeutics (ADAP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Adaptimmune Therapeutics in short term and the buy signal is strong.
Adaptimmune Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Adaptimmune Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Adaptimmune Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.2 and Adaptimmune Therapeutics (ADAP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.